Kennedy-Wilson to Be Acquired in $10.90/Share All-Cash Takeover

BenzingaBenzinga
|||1 min read
Key Takeaway

Kennedy-Wilson agreed to be acquired by a consortium led by CEO McMorrow for $10.90/share in all-cash deal, representing 46% premium. Expected to close Q2 2026.

Kennedy-Wilson to Be Acquired in $10.90/Share All-Cash Takeover

Kennedy-Wilson Holdings Inc. (NYSE: KW) announced a definitive agreement to be acquired by a consortium led by Chairman and Chief Executive Officer William McMorrow in an all-cash transaction valued at $10.90 per share. The offer represents a 46% premium to the company's closing price on November 4, 2025, and follows a strategic review process undertaken by the board. The transaction is expected to close during the second quarter of 2026, subject to customary closing conditions including stockholder approval and regulatory clearance.

Following the completion of the acquisition, Kennedy-Wilson will be delisted from the New York Stock Exchange. The company, which operates as a real estate investment and services firm, will transition to private ownership under McMorrow's leadership consortium. The definitive agreement and transaction timeline provide a clear path to completion, with the board having determined the offer reflects fair value for shareholders in the current market environment.

The all-cash structure eliminates financing risk and provides certainty of value to stockholders. Kennedy-Wilson shareholders will be required to vote on the transaction as part of the approval process. The acquisition represents a significant milestone for the company, which has operated as a publicly traded entity on the NYSE.

Source: Benzinga

Back to newsPublished Feb 17

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Zynex Faces Securities Lawsuit After Bankruptcy, Fraud Settlement in Medical Billing Scandal

Zynex faces securities class action lawsuit following bankruptcy, $85M fraud settlement, and delisting after alleged systematic overbilling scheme.

ZYXIQ
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY